Press release
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing marke
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.
A more than 150-page report to understand trends, opportunity and forecast in MRD testing market to 2031 by technology (flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others), application (hematological malignancies, leukemia, lymphoma, solid tumors, and others), end use industry (hospitals and specialty clinics, diagnostic laboratories, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that Polymerase Chain Reaction (PCR) is expected to witness highest growth over the forecast period.
Within this market, hospitals and specialty clinics will remain the largest segment.
Download sample by clicking on MRD testing market
APAC is expected to witness highest growth over the forecast period.
Labcorp, F. Hoffmann-La Roche, Guardant Health, Sysmex Corporation, Neogenomics Laboratories, Adaptive Biotechnologies Corporation, Archerdx, Asuragen, Arup Laboratories are the major suppliers in the MRD testing market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1-972-636-5056
Explore Our Latest Publications
Hi-Fi System Market
Bearing for Mechanical and Electrical Product
Telecom Electronic Manufacturing Service Market
Timing Device Market
Visual Inspection Microscope Market
Construction Waste Crusher Market
Nonwovens for Construction Market
OSB Panel for Construction Market
Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=lucintel-forecasts-the-global-mrd-testing-market-to-reach-34-billion-by-2031]
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031 here
News-ID: 4000115 • Views: …
More Releases from ABNewswire
Biopreservation Market to Grow at a CAGR of ~7.5% Driven by Rising Demand in Cel …
The biopreservation market is growing rapidly, driven by increased adoption of cell and gene therapies, rising organ transplantation demand, and the need for advanced preservation solutions for biologics and vaccines. With the rise of chronic diseases and advances in regenerative medicine, the demand for reliable technologies like cryopreservation, hypothermic storage, and next-generation perfusion systems is expanding worldwide.
Innovations such as DMSO-free cryopreservation media, advanced hypothermic and normothermic organ perfusion systems, ambient…
Blood Gas and Electrolyte Analyzers Market Poised to Register a CAGR of ~5.65% b …
The blood gas and electrolyte analyzers market is witnessing strong momentum, fueled by the rising global burden of chronic diseases, growing demand for critical care monitoring, and the increasing adoption of point-of-care testing (POCT) in emergency and intensive care settings. These analyzers play a crucial role in measuring parameters such as pH, oxygen, carbon dioxide, electrolytes, and metabolites, enabling timely diagnosis and effective management of critically ill patients.
Technological advancements, including…
Fetal & Neonatal Care Equipment Market Poised to Register a CAGR of ~8.33% by 20 …
The fetal & neonatal care equipment market is experiencing sustained growth, driven by the rising global burden of preterm births, increasing neonatal intensive care unit (NICU) admissions, and advancements in life-saving technologies for newborns. Preterm and low-birth-weight infants remain highly vulnerable, requiring specialized monitoring, respiratory support, and thermal regulation, which is fueling demand for advanced neonatal care solutions worldwide.
Innovations such as non-invasive monitoring systems, advanced neonatal ventilators, smart incubators, phototherapy…
ER+/HER2- Breast Cancer Market Set for Significant CAGR, Driven by Recent FDA Ap …
The ER+/HER2- breast cancer market is projected to experience significant growth through 2034, driven by rising disease prevalence, advancements in targeted therapies, and an expanding pipeline of novel treatment options developed by key players including Radius Pharmaceuticals, Sanofi, Roche, AstraZeneca, Eli Lilly, EQRx, Gilead, Sermonix Pharmaceuticals, Evgen Pharma, Tyme, Roche, Genentech, Daiichi Sankyo, Veru, and others.
DelveInsight's "ER+/HER2- Breast Cancer - Market Insights, Epidemiology and Market Forecast - 2034 [https://www.delveinsight.com/report-store/er-her2-ve-breast-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report…
More Releases for MRD
MRD Testing Market Report: Trends, Forecast and Competitive Analysis to 2031
The future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 with a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology…
Minimal Residual Disease (MRD) Testing Market Booming with Hemato-Oncology Focus …
Minimal Residual Disease (MRD) Testing Market Snapshot
The Minimal Residual Disease (MRD) Testing Market is projected to grow from USD 2.58 billion in 2025 to USD 5.64 billion by 2032, at a CAGR of 11.8% during the forecast period.
Coherent Market Insights proudly presents its latest Minimal Residual Disease (MRD) Testing Market Research Report, delivering a detailed examination of the U.S. Minimal Residual Disease (MRD) Testing Market outlook from 2025 to 2032.…
Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing…
Global MRD Testing Market Set to Reach USD 3.72 Billion by 2030
➤ Global Minimal Residual Disease (MRD) Testing Market to Reach USD 3.72 Billion by 2030, Driven by Technological Advancements and Rising Cancer Incidence
The global Minimal Residual Disease (MRD) Testing Market is projected to expand from USD 1.60 billion in 2023 to USD 3.72 billion by 2030, registering a robust Compound Annual Growth Rate (CAGR) of 12.8% during the forecast period.
➤ Competitive Landscape and Regional Demand
The MRD testing market…
MRD Testing Market Projected To Witness Substantial Growth, 2024-2031
The Latest research report on the MRD Testing Market 2024 provides a comprehensive analysis of the current market landscape, with forecasts extending to 2031. This study combines qualitative and quantitative insights to highlight significant market developments, challenges, competitive dynamics, and potential opportunities and trends shaping the MRD Testing Market. The report covers market size, recent trends, growth projections, market share, and development status. Additionally, it examines government policies,…
MRD Testing Market Expected to Grow at 14.7% CAGR by 2030
The latest report published by VynZ Research, Global MRD Testing Market - Analysis and Forecast (2025-2030), offers a comprehensive analysis of the industry, which comprises insights on the market trends. The report also includes competitor and regional analysis, and contemporary advancements in the market.
Global MRD Testing Market will at USD 3.4 Billion in 2030, and it is anticipated to grow at CAGR 14.7% during the forecast period (2025-2030)…
